Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

PS: The quotes after 2017-05-03 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Teva Pharmaceutic Static Chart

Rise of
+0.21 (+1.52%) Teva Pharmaceutic - [Ticker: TEVA]Chart Teva Pharmaceutic  News Teva Pharmaceutic  Download Historical Prices for Metastock Teva Pharmaceutic and Others  Technical Analysis Teva Pharmaceutic  
Last Trade14.01Last Trade Time2017-11-01 - 19:35:00
Variation+0.21 (+1.52%)Open13.55
Volume21,287,058Average Volume (3m)0
YieldBid / Ask14.01 x 8,100 - 14.02 x 6,000
Former Close13.8052 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.

 News about Teva Pharmaceutic [TEVA]:   (ordered by relevance)
Fitch Revises Teva's Outlook to Stable; Affirms Ratings at 'BB-'  Fitch Ratings Teva loses bid to cancel Corcept drug patent at Federal Circuit  Reuters Teva Leapfrogs Taro With Authorized Generic Epiduo Forte Launch  Generics Bulletin Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement  Business Wire Greenberg Traurig Adds Teva Counsel to Pharma, Health Care Team  Bloomberg Law By selling bonds tied to drug access and climate goals, Teva takes pharma in a new direction - STAT  STAT Pretax profit increases 13% to $364m at Irish arm of Teva  The Irish Times Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working?  FiercePharma Teva launches generic of Epiduo Forte Gel in U.S.  Seeking Alpha Teva Pharmaceutical Industries (NYSE:TEVA) shareholders have endured a 76% loss from investing in the stock five years ago  Simply Wall St Smartworks leases 300 seats to Teva Pharma in suburban Mumbai  Livemint Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.  GlobeNewswire Teva Pharma Highlights Launch Of Authorized Generic Epiduo Forte Gel In US  Benzinga Gan Teva Wraps Up its First ?Semester?  Prince William Living ED Treatment Market Outlook Growth Survey During Pandemic by 2021-2026 | Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, SK Chemicals, Teva Pharma ? UK Parents Lounge  UK Parents Lounge 2 Popular Healthcare Stocks I'd Avoid at All Costs  The Motley Fool 3 Top Stocks That'll Make You Richer in December (and Beyond)  Motley Fool From Cuyana to Teva  Fast Company Mon: ICL, Perrigo lead strong TASE gains  Globes Investors question green tint of Teva's $5bn sustainability bond  Financial Times 5 Warren Buffett Stocks Are Screaming Buys in December  Motley Fool Teva halts output at U.S. drug plant after FDA flags concerns  Reuters Glaxo's Win in Case Against Teva Lifts Other Drugmakers  Bloomberg New branded drugs helping Teva Pharm move closer to growth  Reuters Teva Pharmaceuticals' Motion to Dismiss Denied  Policy & Medicine Why Teva Pharmaceutical Industries Shot Higher Today  The Motley Fool J&J, Teva Beat $50 Billion Opioid Case in First Industry Win  Bloomberg Teva must face government's kickback claims over Copaxone - judge  Reuters Brussels' Teva probe reveals dark side of patent protections  Financial Times Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug  FiercePharma Teva and Bioeq Announce Commercial Partnership for Biosimilar  Business Wire Antitrust: Commission opens formal investigation: Teva  EU News Two pharma giants claim Irish-based Teva breached its patents  The Irish Times Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats  FiercePharma Teva taps new North American commercial chief as key meds Ajovy, Austedo lag their rivals  FiercePharma Fitch Affirms Teva at 'BB-'; Outlook Remains Negative  Fitch Ratings Why Teva Pharmaceuticals Has Two A-Products In The Bag  Seeking Alpha EXCLUSIVE Teva Pharm unlikely to reach deals to co-produce vaccines -CEO  Reuters Teva reaches $925,000 settlement to resolve drug price-fixing claims  PMLiVE Teva to Host Conference Call to Discuss Third Quarter 2021 Financial Results at 8 a.m. ET on October 27, 2021  Business Wire AstraZeneca, Merck KGaA, Pfizer, and Teva Team up with Tech and Investment Leaders to Launch New Biotech Innovation Lab  Pharmaceutical Technology Magazine EPR Podcast Episode 1 - Richard Daniell, Teva Pharmaceuticals  European Pharmaceutical Review Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report  Business Wire Class 2 Medicines Recall: Bristol Laboratories Limited, Brown & Burk UK Ltd, Teva UK Ltd, Irbesartan-containing and Losartan-containing products, EL (21)A/14  GOV.UK After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly $16M  FiercePharma AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals  Business Wire Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021  Business Wire Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021  Yahoo Finance Serial Problem Solver  Pharmaceutical Executive Former Moderna CMO Zaks goes back to his Israeli roots, reemerging as Teva board director  FiercePharma Is Teva Pharmaceutical a Safe Stock to Buy Now?  Motley Fool What To Do After Teva Stock Falls Below $10 Again  Seeking Alpha Teva, Glenmark accuse U.S. government of improperly expanding price-fixing case  FiercePharma Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States  Business Wire Teva and MODAG Tie Up on Potential Parkinson's, MSA Treatment  BioSpace Antitrust: Commission fines Teva and Cephalon ?60.5 million  EU News Teva's Risperidone Injectable Wards Off Schizophrenia Relapse in Phase III  BioSpace Israel-based Teva to invest $42 mln in new drug plant in Bulgaria  SeeNews Is Teva Pharmaceutical Industries (NYSE:TEVA) Using Too Much Debt?  Nasdaq No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds  FiercePharma Teva to close Sudocrem plant in Dublin, 110 jobs to go Teva Pharm sees growth in two main branded drugs in otherwise flat 2021  Reuters Generic-Drug Labeling Strategy Likely to Survive Teva Rehearing  Bloomberg Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazine) Tablets in Adult Patients with Tardive Dyskinesia  Business Wire Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter Teva Partners With Cotopaxi | Shop-Eat-Surf Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the United States  Business Wire Johnson & Johnson, AbbVie, Teva and Endo face $50B opioid trial, pharma's first since 2019  FiercePharma Generic Makers to Challenge Ruling Upholding Teva Cancer Drug  Bloomberg Law Deferasirox-Teva Drug / Medicine Information Teva Is in Discussions to Help Make Covid Vaccines, CEO Says  Bloomberg Teva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to treat high pressure inside the eye, in the United States  Business Wire Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan for the Preventive Treatment of Migraine in Adults  Business Wire English High Court finds Bayer patent obvious in win for Teva  Life Sciences Intellectual Property Review Teva: Biosimilars In The US Will Become Like Complex Generics  Generics Bulletin Teva to Host Conference Call to Discuss First Quarter 2021 Financial Results at 8 a.m. ET on April 28, 2021  Business Wire Teva Enlists Sarah Michelle Gellar to Launch "Inhaler Tales" Campaign to Raise Awareness About Inhaler Use in Asthma and COPD  Yahoo Finance Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors May Contribute to the Significant Under-Diagnosis of Migraine  Yahoo Finance Teva appeals to court to keep 'incredibly damaging' Hollywood parody videos under wraps in New York opioid case  Endpoints News Teva sells its only manufacturing plant in Russia  The Pharma Letter Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate)  Business Wire Teva Sets Ambitious Long-Term Environmental Goals As Part of Teva Pharmaceutical's Ice-Cube Business Model  Seeking Alpha Teva Announces the U.S. Launch of its Generic Version of SOOLANTRA® (ivermectin) Cream, 1% for Once Daily Treatment of Rosacea  Business Wire IN BRIEF: Teva to pay $1.1 mln in Intuniv antitrust settlement  Reuters Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021  Business Wire AbbVie vs.Teva: Which Drug Manufacturing Stock is a Better Choice?  Yahoo Finance Are the Teva ReEmber Shoes So Ugly, They're Good?  InStyle Biogen sues Teva over MS generic  Life Sciences Intellectual Property Review TEVA Pharmaceuticals sells Forest facility to private investor  WSET Teva Canada Provides New Patient Resource to Empower Those Living with Chronic Conditions  Business Wire LoA Update: Teva's extended-release risperidone for schizophrenia sees 5-point boost in regulatory potential following positive Phase III study  Clinical Trials Arena N.Y. jury urged to hold drugmakers liable for U.S. opioid crisis  Reuters GlaxoSmithKline LLC v. Teva Pharms. USA, Inc. | Robins Kaplan LLP - JDSupra  JD Supra Teva Launches TevaForever Recycling Program with TerraCycle | Shop-Eat-Surf Teva joins pharma's help-the-helpers trend with campaign for Canada's COVID caregivers  FiercePharma Teva Wins New Hearing in Glaxo 'Skinny Label' Drug Patent Case  Bloomberg Law Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia  Business Wire Teva UK Enters Erectile Dysfunction Category With First Ever Rx-To-OTC Switch  HBW Insight Pinsent Masons advises Teva Pharmaceuticals on ?84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.
For more news about Teva Pharmaceutic click here:
Teva Pharmaceutic News 

Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2021 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources